Diacylglycerol kinase eta (DGKH) is a key enzyme involved in the regulation of the phosphatidyl inositol pathway. 1 DGKH is located in 13q14, a region in linkage with bipolar disorder (BD). 2 A genomewide association study (GWAS) published in this journal reported strong association between three single nucleotide polymorphisms (SNPs) located in the first intron of DGKH and bipolar disorder I (BDI) in two independent samples. 3 In the attempt to replicate previous findings, we carried out an association study among the three DGKH SNPs and BD in our Sardinian sample of bipolar I patients. Moreover, as a group of patients was characterized for the response to lithium prophylaxis, we tested whether DGKH variants were involved in lithium response.
We genotyped SNPs rs9315885, rs1012053 and rs1170191 in a sample consisting of 197 BDI patients (mean age 43.0±14.8 years; mean age at onset 26.2 ± 10.9 years; 85 men and 112 women) ascertained through the Research Diagnostic Criteria and 300 healthy controls (mean age 42±12 years; 144 men and 155 women). Response to lithium was assessed using the scale developed by Grof et al. 4 Briefly, the scale measures the degree of improvement in the course of the treatment (criterion A) and weighs clinical factors considered relevant in determining whether the improvement observed is due to the lithium treatment (criteria B1-B5). The total score (TS), obtained by subtracting score B from score A, allows us to identify the phenotype of the full response to lithium therapy (TSX7 = full responders; TSp0.6 = others). A total of 91 patients out of 197 were eligible for the study (mean age 46.9 ± 15.0 years; mean age at onset 27.7±11.5 years; 32 men and 59 women). Detailed assessment methods and inclusion criteria for both the case-control and the lithium response samples have been previously described. 5, 6 Genotyping was performed with an ABI PRISM 7000 using TaqMan SNP genotyping assays (Applied Biosystems). Single-marker and haplotype association was carried out using Haploview. 7 None of SNPs tested showed association ( Table 1) . As SNPs were in the same block (as estimated by the solid spine of linkage disequilibrium implemented in Haploview 7 ), we tested three-marker haplotypes only. We showed association for the most common haplotype (H2) that remained significant after the permutation test (P = 0.006; permutation P = 0.025; Table 1 ).
Comparison of alleles and haplotype frequencies between full responders (n = 23) and others (n = 67) showed no statistically significant differences (data not shown). Considering score A on the scale as a quantitative trait, we found no statistically significant differences between genotype groups (results of the Kruskal-Wallis test not shown).
Our study does not replicate the single-marker association reported by Baum et al. 3 However, the significant association for haplotype H2 may reflect the presence of other markers in LD with the block.
The same SNPs were analyzed in the data set of the GWAS performed by the Welcome Trust Case Control Consortium (WTCCC), but no significant association with BD was shown. 8 Nevertheless, the WTCCC reported association for other six SNPs located within 2 kb of DGKH, supporting the hypothesis that the region containing DGHK might be involved in BD. A meta-analysis recently published in this journal combined the data of the two GWAS. 9 Although the results revealed several points of agreement between the two GWAS, the combined data sets did not show association for the DGKH SNPs that were genotyped in both studies.
One limitation of our study is the restricted sample size and then its low power to detect an association of small effect. The power of our sample is decreased even further when the sample is stratified for the response to lithium. Limited power could partially explain the differences in our findings compared to the paper by Baum et al., 3 as well as the lack of association with lithium response. Moreover, although allele frequencies for rs1012053 and rs1170191 were quite similar in the Baum et al. 3 and in our control samples, allele frequencies of rs9315885 were moderately different (T-allele frequency: mean of the two samples = 0.67, Baum et al.
3
; our sample = 0.53). Differences in allele frequencies might be explained by the fact that although Baum et al. 3 and our samples were both of Caucasian ancestry, our sample was consisting of subjects of Sardinian ancestry for at least four generation.
In conclusion, the association for a DGKH haplotype reported in our sample, although intriguing, must be interpreted with caution and further studies need to be performed to clarify the role of DGKH in BD. Finally, the lack of association with the lithium response is far from being considered conclusive. Recently, genome-wide association studies (GWAS) have yielded replicable findings and confirmed previous candidate genes as important factors in non-psychiatric diseases such as type 2 diabetes. 1 However, there has been more controversy of GWAS studies related to bipolar (BP) spectrum disorder and other complex psychiatric traits. Part of the controversy is explained by a small effect of single single nucleotide polymorphisms (SNPs) to the development of these diseases and the difficulty of detecting rare alleles. Also, the diagnosis and lack of measurable physiological parameters in these diseases is still challenging the field. 2 However, three GWAS studies on BP have been published up to date. 1, 3, 4 These recent studies identified several candidate genes but shared only a small amount of findings. 5 In this replication study, our aim has been to elucidate the role of these variants in Finnish BP families.
We have analysed the strongest associating SNPs from the Welcome Trust Case Control Consortium, 1 from Baum et al. and from meta-analysis 5 in a Finnish family-based study sample of BP. From Baum et al. and WTCCC, we selected the best associating SNPs (P-value < 0.0001 and P < 0.000054, respectively) and those SNPs that are located at lithium pathway genes. Altogether we genotyped 26 SNPs in 723 individuals from 180 families with type I bipolar disorder, using Sequenom iPLEX technology. 6, 7 We studied the patients' phenotypic association using dichotomized diagnostic classes of bipolar type I disorder and broad mood disorder spectrum as assessed with Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria. Single SNP and haplotype association analyses were carried out using FBAT 8 coding the unaffected family members as unknown.
Interestingly, we could confirm findings for six associating SNPs: DFNB31, rs10982256, (P < 0.01), SORCS2, rs4411993, rs7683874 and rs10937823, (P < 0.01), SCL39A3, rs4806874, (P < 0.05) and diacylglycerol kinase-Z (DGKH), rs9315885, (P < 0.05). 3, 5 However, no association was seen with SNP rs420259 of PALB2 gene (P = 0.4), which yet mapped the strongest associating genome region in WTCCC study. 1 The association results in Finnish bipolar families are presented in Table 1 .
Interestingly, four SNPs that associated in this study were allelic replications, which further supports the role of these genes as probable players in BP even though the functional variants still remain to be identified. SORCS2 is expressed in the central nervous system, where this receptor is related to act upon synaptic stimuli. 9 All three SNPs from SORCS2 represented the same signal as judged by haplotype analysis. The best signal in this study comes from DFNB31, which remained significant also after correction for multiple testing. It is widely expressed in central nervous system where it might enhance synaptic transmissions. Mutation of this gene cause recessive form of hearing loss. 1, 3 It also gave more significant association in broad mood disorder spectrum making it a candidate gene also in other
